Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at Baseline.

Diabetes, obesity & metabolism·2026
Same author

Diabetes increases the risk of heart failure in myocarditis: a propensity-matched nationwide database analysis.

ESC heart failure·2026
Same author

Risk score for lower-limb amputation and its ability to predict major kidney and cardiovascular events in people with type 1 diabetes.

Cardiovascular diabetology·2026
Same author

Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes.

Diabetes, obesity & metabolism·2026
Same author

Obesity Is Associated with a Lower Risk of Mortality and Readmission in Heart Failure Patients with Diabetes.

Biomedicines·2025
Same author

A Machine Learning Approach to Predictive Modeling of Cardiovascular Events.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025

Related Experiment Video

Updated: May 18, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Cause-specific mortality in diabetes: recent changes in trend mortality.

Charbel Abi Khalil1, Ronan Roussel, Kamel Mohammedi

  • 1Diabetology, Endocrinology and Nutrition Department, Hôpital Bichat-Claude Bernard, Paris, France. charbel.abi-khalil@bch.aphp.fr

European Journal of Preventive Cardiology
|September 20, 2012
PubMed
Summary

Diabetes significantly increases mortality and worsens cardiovascular outcomes. While survival is improving for both type 1 and type 2 diabetes patients, rising obesity rates threaten future progress in reducing diabetes-related deaths.

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Related Experiment Videos

Last Updated: May 18, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Area of Science:

  • Endocrinology
  • Cardiology
  • Public Health

Background:

  • Diabetes mellitus is a major chronic disease in Western populations with higher mortality and poorer cardiovascular prognosis compared to the general population.
  • While advancements in prevention have improved survival rates and life expectancy for diabetic patients, global obesity and sedentary lifestyles are increasing type 2 diabetes incidence.
  • Type 1 diabetes shows decreasing acute complication mortality and a longer disease-free interval before chronic complications, yet overall mortality remains elevated.

Purpose of the Study:

  • To analyze the current trends in diabetes-related mortality and cardiovascular outcomes.
  • To examine the impact of lifestyle factors and preventative measures on diabetes prognosis.
  • To project future trends in diabetes incidence and mortality.

Main Methods:

  • Review of epidemiological data on diabetes prevalence, mortality rates, and cardiovascular events.
  • Analysis of trends in primary and secondary prevention strategies for diabetes.
  • Assessment of the influence of obesity and sedentary lifestyles on diabetes incidence and outcomes.

Main Results:

  • Improved survival and increased life expectancy observed in both type 1 and type 2 diabetes patients.
  • Despite improved outcomes, global mortality for diabetic individuals remains higher than for age- and sex-matched healthy controls.
  • Rising global obesity and sedentary lifestyles are driving an increase in type 2 diabetes incidence, potentially offsetting mortality reduction gains.

Conclusions:

  • Continued improvements in diabetes care and prevention are crucial for enhancing patient survival and quality of life.
  • Addressing the epidemics of obesity and sedentary behavior is essential to curb the rising incidence of type 2 diabetes.
  • Future public health strategies must focus on both managing existing diabetes and preventing new cases to mitigate the long-term burden of the disease.